STIMULATE-ICP-Delphi

As mortality rates from COVID-19 disease fall, the high prevalence of long-term sequelae (Long COVID) is becoming increasingly widespread, challenging healthcare systems globally. Traditional pathways of care for Long Term Conditions (LTCs) have tended to be managed by disease-specific specialties,...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2022-11, Vol.17 (11), p.e0277936
Main Authors: van der Feltz-Cornelis, Christina M, Sweetman, Jennifer, Allsopp, Gail, Attree, Emily, Crooks, Michael G, Cuthbertson, Daniel J, Forshaw, Denise, Gabbay, Mark, Green, Angela, Heightman, Melissa, Hillman, Toby, Hishmeh, Lyth, Khunti, Kamlesh, Lip, Gregory Y. H, Lorgelly, Paula, Montgomery, Hugh, Strain, W. David, Wall, Emma, Watkins, Caroline, Williams, Nefyn, Wootton, Dan G, Banerjee, Amitava
Format: Article
Language:English
Subjects:
Care and treatment
Comorbid patients
Integrated delivery networks
Medical care
Methods
Quality management
United Kingdom
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As mortality rates from COVID-19 disease fall, the high prevalence of long-term sequelae (Long COVID) is becoming increasingly widespread, challenging healthcare systems globally. Traditional pathways of care for Long Term Conditions (LTCs) have tended to be managed by disease-specific specialties, an approach that has been ineffective in delivering care for patients with multi-morbidity. The multi-system nature of Long COVID and its impact on physical and psychological health demands a more effective model of holistic, integrated care. The evolution of integrated care systems (ICSs) in the UK presents an important opportunity to explore areas of mutual benefit to LTC, multi-morbidity and Long COVID care. There may be benefits in comparing and contrasting ICPs for Long COVID with ICPs for other LTCs. This study aims to evaluate health services requirements for ICPs for Long COVID and their applicability to other LTCs including multi-morbidity and the overlap with medically not yet explained symptoms (MNYES). The study will follow a Delphi design and involve an expert panel of stakeholders including people with lived experience, as well as clinicians with expertise in Long COVID and other LTCs. Study processes will include expert panel and moderator panel meetings, surveys, and interviews. The Delphi process is part of the overall STIMULATE-ICP programme, aimed at improving integrated care for people with Long COVID.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0277936